The fatty-acid amide hydrolase inhibitor URB597 inhibits MICA/B shedding

7Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

MICA/B proteins are expressed on the surface of various types of stressed cells, including cancer cells. Cytotoxic lymphocytes expressing natural killer group 2D (NKG2D) receptor recognize MICA/B and eliminate the cells. However, cancer cells evade such immune recognition by inducing proteolytic shedding of MICA/B proteins. Therefore, preventing the shedding of MICA/B proteins could enhance antitumor immunity. Here, by screening a protease inhibitor library, we found that the fatty-acid amide hydrolase (FAAH) inhibitor, URB597, suppresses the shedding of MICA/B. URB597 significantly reduced the soluble MICA level in culture medium and increased the MICA level on the surface of cancer cells. The effect was indirect, being mediated by increased expression of tissue inhibitor of metalloproteinases 3 (TIMP3). Knockdown of TIMP3 expression reversed the effect of URB597, confirming that TIMP3 is required for the MICA shedding inhibition by URB597. In contrast, FAAH overexpression reduced TIMP3 expression and the cell-surface MICA level and increased the soluble MICA level. These results suggest that inhibition of FAAH could prevent human cancer cell evasion of immune-mediated clearance.

References Powered by Scopus

Drug repositioning: Identifying and developing new uses for existing drugs

2541Citations
N/AReaders
Get full text

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

1649Citations
N/AReaders
Get full text

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1377Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Leveraging NKG2D Ligands in Immuno-Oncology

83Citations
N/AReaders
Get full text

Cannabinoids as anticancer drugs: current status of preclinical research

70Citations
N/AReaders
Get full text

The endocannabinoid system as a pharmacological target for new cancer therapies

25Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sekiba, K., Otsuka, M., Seimiya, T., Tanaka, E., Funato, K., Miyakawa, Y., & Koike, K. (2020). The fatty-acid amide hydrolase inhibitor URB597 inhibits MICA/B shedding. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-72688-y

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

50%

Researcher 2

33%

Professor / Associate Prof. 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

50%

Biochemistry, Genetics and Molecular Bi... 1

17%

Nursing and Health Professions 1

17%

Immunology and Microbiology 1

17%

Save time finding and organizing research with Mendeley

Sign up for free